Trump has repeatedly threatened to drastically slash NIH funding, but its new $37 billion budget is a historic high.
The Bidens have convened a diverse board and staff with the goal of continuing efforts to accelerate research and development begun under the Cancer Moonshot Initiative.
Discover's D-brief blog ponders the future of the Cancer Moonshot initiative.
The law contains provisions that proponents say will advance precision medicine and speed new tests to market, but critics worry if this will come at a cost to public health.
Personalized medicine proponents are uncertain where funding, personnel, and priorities will land in a new administration and Congress.
NantHealth, CHOP, and their collaborators intend to release genomic, transcriptomic, and proteomic data from 1,600 patients in the next six months
The update includes several key initiatives such as a liquid biopsy database, a DoD-led longitudinal study, and NCI cloud collaborations with Amazon and Microsoft.
Among the Blue Ribbon Panel's recommendations, several involve using molecular information to investigate the development and progression of cancer.
An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.
In Science this week: reduction in bee phylogenetic diversity, and more.
The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.